Skip to main content
. 2015 Feb 17;75(4):791–803. doi: 10.1007/s00280-015-2701-3

Fig. 2.

Fig. 2

Prediction-corrected visual predictive checks of the binding model based on 1000 simulations (panel a total bevacizumab, panel b free VEGF165). Median (solid line), 10th and 90th percentiles (dashed lines) of the observed data (circles) are compared to the 95 % confidence intervals (shaded areas) for the median, 10th and 90th percentiles of the simulated data